Clinical Trials Logo

Clinical Trial Summary

Compare open and laparoscopic assisted pancreaticoduodenectomy regarding intraoprative blood loss, organ injury, completion of planned laparoscopic steps, duration and early post operative course of pain, hem stability, oral feeding, leakage(pancreatic, billary and intestinal). ,bleeding, mortality, lymph nodes and safety margins .


Clinical Trial Description

Pancreaticoduodenectomy is the only option curative intended in the treatment of resectable pancreatic ductal adenocarcinomas, duodenal carcinoma, ampullary carcinoma, lower common bile duct cholangiocarcinoma,. It is still associated with very high morbidity and mortality. [1]. Pancreatic cancer ranks as the seventh leading cause of cancer-related death worldwide, and the fourth among other cancers[2,3]. In recent years, the minimally invasive techniques has considered revolution in surgeries of pancreatic cancers [4,5]. Laparoscopic assisted pancreaticoduodenectomy is a hybrid procedure combining laparoscopic resection and reconstruction through a small incision.it companies laparoscopic mobilization and dissection due to magnification compared with open pancreaticoduodenectomy[6]. Several studies have shown that laparoscopic assisted pancreaticoduodenectomy could result in less blood loss less, pain ,less wound infection and shorter hospital stay compared to open pancreaticoduodenectomy[7,8]. Limited literature described the safety and efficacy of laparoscopic assisted pancraticododenostomy .Also such comparative studies deficient in evaluation of outcomes of laparoscopic assisted pancraticododenostomy and open pancraticoduodenoctomy.So the interest of our study is to compare between the feasibility and safety of laparoscopic assisted pancraticododenostomy and open pancraticoduodenoctomy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05463328
Study type Interventional
Source Assiut University
Contact mohammed aly ahmed, Assist.lecturer
Phone 01067575588
Email mohamed1234ali1991@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 1, 2022
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05351983 - Patient-derived Organoids Drug Screen in Pancreatic Cancer N/A
Recruiting NCT05155878 - Prognostic Factors in Periampullary Tumors and Cysts
Completed NCT03834701 - Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms N/A
Recruiting NCT04164602 - The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
Active, not recruiting NCT05095831 - EUS Shear Wave for Solid Pancreatic Lesions.
Recruiting NCT04783844 - Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors
Recruiting NCT03570502 - Incidence of POPF in the Resection of the Left Pancreas With RFAT
Recruiting NCT04783831 - Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy
Not yet recruiting NCT06381882 - The Role of the Human Microbiome in Patients After Pancreatic Resection.
Not yet recruiting NCT04336839 - Portal Vein Resection in Pancreatic Neuroendocrine Tumours
Recruiting NCT05714111 - Radiology Registry on Pancreatic Malignancies
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06344507 - Iconographic Registry of Pancreatobiliary Endoscopy Procedures
Recruiting NCT04104230 - Quebec Pancreas Cancer Study
Recruiting NCT05371223 - Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases Phase 2
Recruiting NCT04687410 - Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs N/A
Completed NCT04724551 - The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula
Withdrawn NCT03649035 - Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma Phase 3
Recruiting NCT04841616 - Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions N/A
Completed NCT05711433 - Risk Factors for Postoperative Pancreatic Fistula Following Non-traumatic Pancreatic Surgery. Retrospective Observational Study.